CAS RN: 220364-22-7
[3-(4-BROMO-BENZYL)-3H-IMIDAZOL-4-YL]-METHANOL
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 220364-22-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
220364-22-7 / [3-[(4-bromophenyl)methyl]imidazol-4-yl]methanol
Standard CAS: 220364-22-7
Multi CAS: No
Basic Information
copy
CAS
220364-22-7 copy
Multi CAS
No copy
Molecular Formula
C11H11BrN2O copy
Molecular Weight
267.120000 copy
Exact Mass
266.005480 copy
SMILES
C1=CC(=CC=C1CN2C=NC=C2CO)Br copy
InChI
InChI=1S/C11H11BrN2O/c12-10-3-1-9(2-4-10)6-14-8-13-5-11(14)7-15/h1-5,8,15H,6-7H2 copy
InChIKey
JLBQCMBTWCNPRZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.18 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
61.39 copy
TPSA
38.05 copy
LogP / Solubility
WLOGP
2.19 copy
MLOGP
1.93 copy
XLogP3
1.4 copy
Consensus LogP
1.84 copy
Log S (ESOL)
-3.22 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.33 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.57 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.8 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy